Related Experiment Videos
Increasing peak expiratory flow time in amyotrophic lateral sclerosis
Steven R Wilson1, Mackenzie A Quantz, Michael J Strong
1Division of Respirology, London Health Sciences Center, London, ON, Canada.
Chest
|January 18, 2005
Summary
Peak expiratory flow time (PEFT) increases linearly over time in amyotrophic lateral sclerosis (ALS) patients, indicating declining pulmonary function. This measure is more sensitive than FVC or PEFR declines.
Area of Science:
- Neurology
- Pulmonology
- Biomedical Engineering
Background:
- Pulmonary function tests are crucial for monitoring respiratory muscle strength decline in amyotrophic lateral sclerosis (ALS).
- Established measures include FVC, FEV1, and maximal pressures, but a more sensitive indicator is sought.
- Increasing peak expiratory flow time (PEFT) is proposed as a sensitive marker for respiratory decline in ALS.
Purpose of the Study:
- To investigate peak expiratory flow time (PEFT) as a quantitative measure of pulmonary function decline in ALS patients.
- To compare the sensitivity of PEFT changes with traditional pulmonary function measures like FVC and PEFR.
Main Methods:
- Fifty-five ALS patients underwent serial flow-volume loop measurements.
- Changes in FVC, PEFR, and PEFT were correlated with baseline values.
- Statistical analyses included Spearman correlation, Kruskal-Wallis, Dunn, and Mann-Whitney tests.
Main Results:
- PEFT significantly increased from baseline in all follow-up tests.
- PEFT showed significant negative correlations with decreasing PEFR and FVC.
- PEFT increased linearly with time and at a faster rate than FVC and PEFR declined.
Conclusions:
- PEFT is a sensitive, quantitative, and easily measurable indicator of pulmonary function decline in ALS.
- PEFT increases linearly with disease progression, potentially plateauing with bulbar symptoms.
- PEFT demonstrates greater sensitivity to respiratory muscle weakness than FVC or PEFR.